162.85MMarket Cap-8647P/E (TTM)
5.769High5.131Low25.70KVolume5.640Open5.630Pre Close140.37KTurnover2.57%Turnover RatioLossP/E (Static)29.61MShares20.72052wk High53.92P/B5.50MFloat Cap4.76052wk Low--Dividend TTM1.00MShs Float20.720Historical High--Div YieldTTM11.33%Amplitude4.760Historical Low5.461Avg Price1Lot Size
Telomir Pharmaceuticals Stock Forum
NEWS
Telomir Pharmaceuticals Unveils Compelling Pre-clinical Data on Age-Reversal Drug Telomir-1 at National Press Club Event in Washington, D.C.
Telomir Pharmaceuticals presents promising pre-clinical data on Telomir-1 at a National Press Club event, showcasing a 40% increase in telomerase activity and lengthening of telomeres in human cells. The company plans to initiate human clinical trials for osteoarthritis and veterinary trials in 2025 after pre-clinical...
No comment yet